Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

GERD

- PMLiVE

FDA panel backs Takeda’s inflammatory bowel disease drug

Vedolizumab on course for US approval to treat Crohn’s disease and ulcerative colitis

- PMLiVE

Takeda appoints GSK’s Weber as chief operating officer

Could take on CEO role next year

- PMLiVE

International health app site launches

MyHealthApps aims to help bring the technology into mainstream healthcare

- PMLiVE

Text messages studied as tool for cutting type 2 diabetes risk

Imperial College London teams up with Rapide

- PMLiVE

Mobile health apps – still a novelty?

There are thousands of mobile health apps, but they've yet to live up to their potential

mHealth adoption varies by therapy area

Cystic fibrosis patients most likely to be mobile health users, says survey

- PMLiVE

Big increase in US mobile health audience

Some 95 million adults now use their phone for health purposes

Google Glass passes clinical ‘proof of concept’

Philips-Accenture project trials patient data delivery via smart-glasses

- PMLiVE

Sanofi launches a monster mobile diabetes game

Monster Manor iPhone and Android apps aim to encourage better management of the condition

- PMLiVE

Pfizer calls for mHealth to be prioritised

Wants more action to support mobile health in developing countries' ageing populations

- PMLiVE

New US drug discovery institute partners with Takeda

Tri-Institutional Therapeutics Discovery Institute to cover communicable, chronic and rare conditions

African pilot to gauge mHealth training potential

Kenyan project focuses on maternal health information and education

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links